Copy Link Print Information

Rosiglitazone maleate

(Synonyms: BRL 49653C)
189 Cited Publications
Customer Review

Based on 189 publication(s) in Google Scholar

Rosiglitazone maleate (BRL 49653C) is a potent and selective activator of PPARγ, with EC50s of 30 nM, 100 nM and 60 nM for PPARγ1, PPARγ2, and PPARγ, respectively, and a Kd of appr 40 nM for PPARγ; Rosiglitazone maleate is also an modulator of TRP channels, inhibits TRP melastatin 2 (TRPM2), TRPM3 and activates TRP canonical 5 (TRPC5).

For research use only. We do not sell to patients.

  • Purity: 99.73%
  • CAS No.: 155141-29-0
  • Formula: C22H23N3O7S
  • Molecular Weight:473.50
  • Storage:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Rosiglitazone maleate Chemical Structure
    Rosiglitazone maleate Chemical Structure
  • Experimental Validation Results for Rosiglitazone maleate
  • Experimental Validation Results for Rosiglitazone maleate
  • Experimental Validation Results for Rosiglitazone maleate
  • Experimental Validation Results for Rosiglitazone maleate
  • Experimental Validation Results for Rosiglitazone maleate
  • Experimental Validation Results for Rosiglitazone maleate
  • Experimental Validation Results for Rosiglitazone maleate
  • Experimental Validation Results for Rosiglitazone maleate
  • Experimental Validation Results for Rosiglitazone maleate
  • Experimental Validation Results for Rosiglitazone maleate
  • Experimental Validation Results for Rosiglitazone maleate
CAS No.: 155141-29-0
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Rosiglitazone maleate:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocol
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Rosiglitazone maleate

More
Customer Validation & Images
WBRT-PCRIFCell Proliferation/Viability Assay
  • RT-PCR
  • WB
  • RT-PCR
  • WB
  • Cell Proliferation/Viability Assay
  • WB
  • WB
  • WB
  • IF
  • IF
  • WB

All PPAR Isoforms

More

All TRP Channel Isoforms

More
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Rosiglitazone maleate Chemical Structure
    Rosiglitazone maleate Chemical Structure
    1/16
  • 1/16

    Rosiglitazone maleate purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Sep 10;16(1):8215. [Abstract]

    Customer Validation
     NECTIN4 mRNA levels in RT112 cells treated with 1μM Rosiglitazone and T0070907 (T007) for 72 h.

  • 1/16

    Rosiglitazone maleate purchased from MedChemExpress. Usage Cited in: Cell Metab. 2023 Nov 7;35(11):1915-1930.e8. [Abstract]

    Customer Validation
     C3H10T1/2 preadipocytes were treated with differentiation medium supplemented with 0.5 mM 3-isobutyl-1-methylxanthine, 1 μM Dexamethasone, 850 nM Insulin, 1 nM Triiodothyronine, 125 nm Indomethacin and 1 μM Rosiglitazone for 2 days and subsequently cultured in maintaining medium supplemented with 1 nM Triiodothyronine, 850 nM Insulin, and 1 μM Rosiglitazone for another 2 days. Differentiated adipocytes at day 4 were cultured in complete medium until used for experiments. Representative immunoblots of PGC-1α and UCP1 in beige adipocytes treated as indicated.

  • 1/16

    Rosiglitazone maleate purchased from MedChemExpress. Usage Cited in: Cell Metab. 2023 Dec 5;35(12):2165-2182.e7. [Abstract]

    Customer Validation
     Relative GDF15 mRNA expression and GDF15 release in human primary hepatocytes treated with 10 μM rosiglitazone for 48 h.

  • 1/16

    Rosiglitazone maleate purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 Jun 2;14(1):3208. [Abstract]

    Customer Validation
     C3H10T1/2 preadipocytes were cultured in DMEM supplemented with 10% FBS, 1% P/S. For adipogenic differentiation, confluent C3H10T1/2 preadipocytes were incubated with complete medium supplemented with 0.5 mM 3-isobutyl-1-methylxanthine, 1 μM Dexamethasone, 850 nM Insulin, 1 nm Triiodothyronine, 125 nm Indomethacin and 1 μM Rosiglitazone for 2 days. Then, cells were changed to the complete medium supplemented with 1 nM T3, 850 nM Insulin, and 1 μM Rosiglitazone for another 2 days. Differentiated adipocytes at day 4 were maintained in complete medium until used for experiments. Representative immunoblots of NRP1 and EPHA7 in differentiated brown adipocytes transfected with si-Rbm3 or si-NC.

  • 1/16

    Rosiglitazone maleate purchased from MedChemExpress. Usage Cited in: Carcinogenesis. 2023 May 27;44(3):242-251. [Abstract]

    Customer Validation
     Rosiglitazone (ROSI; 15, 30, 60, 120, 240 µM; 24 h) significantly inhibits the growth of NCI-H929 and OPM-2 cells.

  • 1/16

    Rosiglitazone maleate purchased from MedChemExpress. Usage Cited in: Cell Metab. 2021 Mar 2;33(3):581-597.e9. [Abstract]

    Customer Validation
     Protein expression of PPRC1 and PPARG in HepG2 cells exposed to PA and treated with RGZ (Rosiglitazone) (30 mmol/L; 24 h), as analyzed by western blot.

  • 1/16

    Rosiglitazone maleate purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2019 Jan 15:843:134-144. [Abstract]

    Customer Validation
     Protein levels of BACE1 and APP are measured by western blot assay in cerebral cortex of 12-month-old AD mice with different treatments (RSG and GW9662).

  • 1/16

    Rosiglitazone maleate purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2019 Jan 15:843:134-144. [Abstract]

    Customer Validation
     Protein levels of sAPPα and sAPPβ are measured by western blot assay in cerebral cortex of 12-month-old AD mice with different treatments (RSG and GW9662).

  • 1/16

    Rosiglitazone maleate purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2019 Jan 15:843:134-144. [Abstract]

    Customer Validation
     PPARγ level is determined by IF assay in 3×Tg-AD mice, 3×Tg-AD mice with RSG treatment, 3×Tg-AD-KO mice, 3×Tg-AD-KO mice with GW9662 stimulation.

  • 1/16

    Rosiglitazone maleate purchased from MedChemExpress. Usage Cited in: Free Radic Biol Med. 2018 Oct:126:259-268. [Abstract]

    Customer Validation
     Laser confocal microscope is performed to measure MMP indicated with the ratio of JC-1 Red/JC-1 Green. Nuclei are counterstained with DAPI (blue). Bar graphs represent the mean ± SD of red/green fluorescence intensity.

  • 1/16

    Rosiglitazone maleate purchased from MedChemExpress. Usage Cited in: Front Mol Neurosci. 2017 Sep 14:10:293. [Abstract]

    Customer Validation
     Rosiglitazone enhances the phosphorylation of insulin receptor substrate 1 (IRS1, phosphorylated at Ser 636/639), which is considered to be the main activator of the Akt/mTOR pathway by IGF-1R.

  • Rosiglitazone maleate